LI85008F

09/20/2012 - "The effect of an herbal formulation LI85008F on weight loss in obese human subjects was evaluated in an 8-weeks randomized, double-blind, placebo-controlled study (Clinical Trial Registration no. ISRCTN37381706). "
09/20/2012 - "The herbal formulation LI85008F (Adipromin) is prepared from commonly used medicinal plants extracts, which provides useful and safe application for weight loss in obese humans. "
11/01/2018 - "To re-evaluate the weight loss efficacy of LI85008F in healthy overweight adults via a 16-week randomized, double-blind, placebo-controlled clinical study. "

11/01/2018 - "The unique herbal extract blend LI85008F, combined with modest calorie restriction and physical activity, is well tolerated, safe, and effective for weight management in overweight men and women."
11/01/2018 - "One hundred and forty overweight participants (body mass index [BMI] 27-29.9 kg/m2 , 29.3% male; ages 21-50 years) were randomized into placebo (n =70) and LI85008F (n =70) groups. "
11/01/2018 - "To re-evaluate the weight loss efficacy of LI85008F in healthy overweight adults via a 16-week randomized, double-blind, placebo-controlled clinical study. "

02/01/2010 - "In diet-induced obese rats, LI85008F significantly reduced weight gain and improved serum adiponectin levels. "

11/01/2018 - "At the end of the trial period, the LI85008F supplemented group showed significant reductions in body weight (5.36 ± 1.769 vs. 0.87 ± 1.381 kg; P < 0.0001) and BMI (2.05 ± 0.693 vs. 0.34 ± 0.559 kg/m2 ; P < 0.0001), compared with placebo. "
09/20/2012 - "At the end of the trial period, LI85008F supplemented group showed significant net reductions in body weight and Body Mass Index (BMI). "
01/01/2021 - "Our results indicated that LI85008F can suppress body weight gain and lower whole-body fat mass in HFD-induced obese mice. "
08/28/2020 - "The present data suggest that LI85008F reduces body fat mass and controls body weight gain via increasing energy metabolism in combination with reduced lipogenesis in diet-fed obese rats."
02/01/2010 - "The NOAEL of LI85008F was found to be greater than 2500 mg/kg body weight. "

09/20/2012 - "In addition, Adipokine profiling study in 3T3-L1 adipocytes demonstrates that LI85008F modulates key regulatory factors of adipogenic differentiation and insulin sensitivity, such as Adiponectin, Pref-1, and resistin. "